What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001166309
Total reported value
$150.1M
$150.1M
31 檔
67.3%
As reported in its official Q1 2024 Form 13F filing, Bridger Management, LLC's tracked investment portfolio stood at $150.1M with 31 total positions.
In Q1 2024, Bridger Management, LLC displayed an active expansion posture, initiating 10 new positions and adding to 8 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UBER | Uber Technologies Inc | Stock-Industrials | 10.46% | -0.47% | -32.31% | |
| 2 | LLY | Eli Lilly & Co | Stock-Healthcare | 9.85% | +1.27% | — | |
| 3 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 9.54% | -0.35% | — | |
| 4 | MS | Morgan Stanley | Stock-Financials | 7.97% | +1.20% | +3.19% | |
| 5 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 7.74% | — | -14.48% | |
| 6 | BBWI | Bath & Body Works Inc | Stock-Consumer Disc | 5.83% | — | -22.24% | |
| 7 | 0C3 | Endeavor Group Hold-class A | Stock-Other | 5.12% | — | +1.05% | |
| 8 | PFE | Pfizer Inc | Stock-Healthcare | 4.38% | — | — | |
| 9 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.15% | — | — | |
| 10 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 3.57% | — | +179.69% | |
| 11 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 3.21% | — | +42.92% | |
| 12 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 3.18% | — | — | |
| 13 | CZR | Caesars Entertainment Inc | Stock-Consumer Disc | 2.91% | — | -65.50% | |
| 14 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 2.85% | — | — | |
| 15 | MLCO | Melco Resorts & Entert-adr | Stock-Other | 2.81% | -0.48% | +302.81% | |
| 16 | CYTK | Cytokinetics Inc | Stock-Healthcare | 2.18% | — | +207.02% | |
| 17 | GERN | Geron CORP | Stock-Other | 1.99% | — | — | |
| 18 | DXCM | Dexcom Inc | Stock-Healthcare | 1.81% | -0.43% | — | |
| 19 | QTRX | Quanterix CORP | Stock-Other | 1.65% | — | — | |
| 20 | ATRC | Atricure Inc | Stock-Other | 1.37% | — | +14.58% | |
| 21 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.33% | — | — | |
| 22 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 0.95% | +0.25% | — | |
| 23 | QURE | uniQure N.V. | Stock-Other | 0.85% | — | — | |
| 24 | ✓ | Hillevax Inc | Stock-Other | 0.81% | — | — | |
| 25 | MSFT | Microsoft CORP | Stock-Tech | 0.80% | -0.50% | +29.16% | |
| 26 | 430 | Terns Pharmaceuticals Inc | Stock-Other | 0.73% | — | — | |
| 27 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 0.63% | — | — | |
| 28 | TOST | Toast Inc-class A | Stock-Tech | 0.59% | -0.09% | — | |
| 29 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.59% | -0.25% | — | |
| 30 | NEXT | Nextdecade CORP | Stock-Other | 0.17% | -0.07% | — | |
| 31 | SRZNW | Surrozen Inc-cw25 | Stock-Other | 0.01% | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | THC | Tenet Healthcare CORP | +4.2% | NEW | New buy |
| 2 | LLY | Eli Lilly & Co | +3.5% | — | Unchanged |
| 3 | TEVA | Teva Pharmaceutical-sp Adr | +3.5% | — | Unchanged |
| 4 | TSM | Taiwan Semiconductor-sp Adr | +3.2% | NEW | New buy |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | +2.2% | +179.69% | Add |
| 6 | MLCO | Melco Resorts & Entert-adr | +2.1% | +302.81% | Add |
| 7 | GERN | Geron CORP | +2% | NEW | New buy |
| 8 | DXCM | Dexcom Inc | +1.8% | NEW | New buy |
| 9 | SWTXUSD | Springworks Therapeutics Inc | +1.8% | +42.92% | Add |
| 10 | CYTK | Cytokinetics Inc | +1.5% | +207.02% | Add |
| 11 | MS | Morgan Stanley | +1.4% | +3.19% | Add |
| 12 | 0C3 | Endeavor Group Hold-class A | +1.1% | +1.05% | Add |
| 13 | ✓ | Hillevax Inc | +0.8% | NEW | New buy |
| 14 | 430 | Terns Pharmaceuticals Inc | +0.7% | NEW | New buy |
| 15 | SPOT | Spotify Technology S.A. | +0.6% | NEW | New buy |
| 16 | TOST | Toast Inc-class A | +0.6% | NEW | New buy |
| 17 | AMZN | Amazon.com Inc | +0.6% | NEW | New buy |
| 18 | PFE | Pfizer Inc | +0.5% | — | Unchanged |
| 19 | MSFT | Microsoft CORP | +0.3% | +29.16% | Add |
| 20 | BBWI | Bath & Body Works Inc | +0.3% | -22.24% | Trim |
| 21 | XENE | Xenon Pharmaceuticals Inc | +0.2% | — | Unchanged |
| 22 | VRTX | Vertex Pharmaceuticals Inc | +0.2% | -14.48% | Trim |
| 23 | GOOGL | Alphabet Inc-cl A | +0.2% | — | Unchanged |
| 24 | NEXT | Nextdecade CORP | +0.2% | NEW | New buy |
| 25 | ATRC | Atricure Inc | +0.2% | +14.58% | Add |
| 26 | CPRX | Catalyst Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 27 | QTRX | Quanterix CORP | 0% | — | Unchanged |
| 28 | SRZNW | Surrozen Inc-cw25 | 0% | — | Unchanged |
| 29 | UBER | Uber Technologies Inc | -0.1% | -32.31% | Trim |
| 30 | QURE | uniQure N.V. | -0.1% | — | Unchanged |
| 31 | ✓ | Williams Rowland Acquisition | -1.2% | EXIT | Sold out |
| 32 | ACAD | Acadia Pharmaceuticals Inc | -1.4% | EXIT | Sold out |
| 33 | CCK | Crown Holdings Inc | -3.5% | EXIT | Sold out |
| 34 | DCBO | Docebo Inc | -3.6% | EXIT | Sold out |
| 35 | CHTR | Charter Communications Inc-a | -4% | EXIT | Sold out |
| 36 | CZR | Caesars Entertainment Inc | -4.8% | -65.50% | Trim |
| 37 | USFD | US Foods Holding CORP | -5.5% | EXIT | Sold out |
| 38 | GDDY | Godaddy Inc - Class A | -9.7% | EXIT | Sold out |
According to official SEC Form 13F filings, Bridger Management, LLC reported a total U.S. public equity portfolio value of $150.1M across 31 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UBER, LLY, TEVA) accounted for 67.3% of total reported equity market value during Q1 2024.
Top New Position Initiated
THC
市值: $9.2M
Top Position Liquidated / Trimmed
GDDY
前期市值: $25.1M
During Q1 2024, Bridger Management, LLC's top holdings by market value included UBER (10.5%)、LLY (9.8%)、TEVA (9.5%). The largest single position, UBER, represented 10.5% of total portfolio value.
In Q1 2024, Bridger Management, LLC made 29 total portfolio adjustments, initiating 10 new buys, adding to 8 positions, trimming 4 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.